CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
adjuvant chemotherapy regimen in patients with early-stage luminal B breast cancer.The primary endpoint will be to evaluate the fea...
Phase 2
Milan, Italy
Breast cancer is the most common form of cancer among women. For patients candidated for adjuvant chemotherapy and endocri...
Phase 3
Milano, MI, Italy and 73 other locations
adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...
Phase 2
Monza, Italy and 72 other locations
-positive / HER2-negative breast cancer which has spread beyond the original tumor and/or to other organs.During this stud...
Phase 3
Milan, Italy and 52 other locations
the primary and metastatic (or relapsed) tumor will be collected for central analyses, together with blood, serum and plasma samples. Any s ...
Milano, Italy and 51 other locations
This study will be conducted in patients with metastatic breast cancer who have specific Fibroblast Growth Factor Receptor gene abn...
Phase 2
Milano, Italy and 36 other locations
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...
Phase 1, Phase 2
Milan, Italy and 71 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Milano, Italy and 117 other locations
This study to learn more about olaparib and olaparib plus durvalumab combination therapy and also to better understand the studied disease, breast...
Phase 2
Rozzano, Italy and 43 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
Milano, Italy and 226 other locations
Clinical trials
Research sites
Resources
Legal